Skip to main content
SpringerLink
Log in

Hepatitis B vaccine recombinant (Janssen/Medeva)

Hepageneℳ

  • Section 2: Prophylactic Anti-Infective Vaccines
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wagner D, Wagenbreth I, Stachan-Kunstyr R, et al. Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa Gene 3 containing pre-S1, pre-S2, and S gene products. Clin Investig 1994 May; 72: 350–2

    PubMed  CAS  Google Scholar 

  2. Medeva’s new product pipeline. Scrip 1997 Jan 31; 2202: 14

    Google Scholar 

  3. Medeva hep-B vaccine 1st phase III data. Scrip 1996 May 3; 2125: 20

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hepatitis B vaccine recombinant (Janssen/Medeva). Drugs R&D 2, 201–202 (1999). https://doi.org/10.2165/00126839-199902030-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902030-00011

Keywords

Search

Navigation